GlycoMimetics 8-K Shows Pfizer Said Ongoing Phase 3 Trial With Rivipansel Is ~75% Enrolled, Pfizer Delayed Timeline For Complete Enrollment From 2H'18 To Early 2019, Top-Line Data Available From End OF 2018 To Q2'19
Benzinga Newsdesk